Found 20 matching trials
Gamma Delta T-cell Infusion for AML at High Risk of Relapse After Allo HCT
PHASE1The purposes of the study are to determine the maximum tolerated dose (MTD)...
Status
Active Not Recruiting
Location
Moffitt Cancer Center
A Phase II Safety and Tolerability Study of TCB008 in Patients With COVID-19
PHASE2A Phase II safety and tolerability study of expanded gamma delta T cell lym...
Location
Royal Victoria Infirmary
Allogeneic NKG2DL-targeting CAR γδ T Cells (CTM-N2D) in Advanced Cancers (ANGELICA)
PHASE1CAR-T is a pioneering cancer treatment which has found success in some canc...
Location
National University Hospital
Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC
PHASE1This is a phase 1 single center clinical trial for patients with end stage ...
Location
Moffitt Cancer Center
Study of GDX012 in Patients With MRD Positive AML
PHASE1The purpose of this first-in-human study is to assess the safety, tolerabil...
Novel Gamma-Delta (γδ)T Cell Therapy for Treatment of Patients With Newly Diagnosed Glioblastoma
PHASE1This study is being conducted to find out if the safety and tolerability of...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Association of T Gamma Delta-CD16+ Cells and Anti-CMV Immunoglobulins in the Prevention of CMV Infection
PHASE2CMV infection in transplantation remains the most frequent infectious compl...
Location
Hopital Pellegrin
A Phase 1 Study of ADI-001 in B Cell Malignancies
PHASE1This is a Phase 1 dose escalation study following a 3+3 study design. The p...
Location
Stanford University Medical Center
Ex-vivo Expanded γδ T-lymphocytes (OmnImmune®) in Patients With Acute Myeloid Leukaemia (AML)
PHASE1This study investigates the potential curative properties of gamma delta T-...
Location
UHKT (Ustav hematologie a krevni transfuze)
Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
EARLY_PHASE1This study aims to improve the treatment of blood cancer by using exercise ...
Location
The University of Arizona